Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Liver beneficial pharmaceutical composition and method for preparing the same

A composition and drug technology, applied in the field of Gankang pharmaceutical composition and its production, can solve the problems of no antiviral drug for treating chronic hepatitis, unsatisfactory treatment results, toxic and side effects of antiviral drugs, etc. The effect of chronic liver fibrosis development, accelerated liver blood flow, easy production method

Active Publication Date: 2008-04-30
深圳利孚生物科技有限公司
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are many kinds of antiviral drugs for chronic hepatitis, the virus of chronic hepatitis is easy to mutate, thereby forming drug resistance or reducing its curative effect, and because of the toxic and side effects of antiviral drugs, there is no such drug so far. Ideal antiviral drug for chronic hepatitis
At the same time, for chronic hepatitis, the current clinical treatment results of traditional Chinese medicine and modern medicine are not satisfactory, and the high cost of treatment also makes it unaffordable for most patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liver beneficial pharmaceutical composition and method for preparing the same
  • Liver beneficial pharmaceutical composition and method for preparing the same
  • Liver beneficial pharmaceutical composition and method for preparing the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Example 1, the Korean Gankang pharmaceutical composition contains 8 parts of ginseng, 10 parts of white peony, 10 parts of Ningqi, 7 parts of Rhizoma Chuanxiong, 7 parts of Cyperus cyperi, 16 parts of perilla oil, 22 parts of mushrooms, and 16 parts of perilla oil in parts by weight of raw materials. 8 parts of kernels, 8 parts of chicken yellow, 220 parts of duck meat, and 2 parts of licorice.

Embodiment 2

[0013] Example 2, the Korean Gankang pharmaceutical composition contains 10 parts of ginseng, 14 parts of white peony, 14 parts of Ningqi, 8 parts of Rhizoma Chuanxiong, 8 parts of Cyperus cyperi, 33 parts of perilla oil, 28 parts of mushrooms, and 33 parts of perilla oil in parts by weight of raw materials. 10 parts of kernels, 12 parts of chicken yellow, 280 parts of duck meat, and 5 parts of licorice.

Embodiment 3

[0014] Example 3, the Korean Gankang pharmaceutical composition contains 8 parts of ginseng, 14 parts of white peony, 10 parts of Ningqi, 8 parts of Chuanxiong, 7 parts of Cyperus cyperi, 33 parts of perilla oil, 22 parts of mushrooms, 33 parts of perilla oil, 22 parts of mushrooms, and 10 parts of kernels, 8 parts of chicken yellow, 280 parts of duck meat, and 2 parts of licorice.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This is a Korean liver-recovering drug composition, which contains pseudoginseng, suzi oil, duck meat, and so on. Its preparing method is: firstly disintegrate the needed pseudoginseng to fine, twist the needed duck meat to pieces and add some needed suzi oil, then mix with the fine, stew with middle fire, then low temperature dry and disintegrate to obtain drug powder; extract and condense the rest drug liquid such as white peony root to prepare cream, mix it with the drug powder above to achieve half-finished product; whose functions are: stabilize the foundation and strengthen the body, easing liver and regulating the flow of qi, suscepting vagina, strengthening the spleen and stomach; it can effectively cure viral hepatitis, liver ascites, alcohol liver, fat liver, cirrhosis, and other chronic hepatitis, and can depress the fat in liver and blood, attend liver, strengthen microcirculation of liver blood stream and liver main substance, decrease liver gore, accelerate liver blood stream speed, prevent liver chronic fibrosis development, slow down fibrosis course, stimulate hepatocyte regenesis. This preparing method is easy to carry out and relatively cost low.

Description

technical field [0001] The invention relates to a pharmaceutical composition and a production method thereof, which is a Koryo Gankang pharmaceutical composition and a production method thereof, and is suitable for treating chronic hepatitis such as viral hepatitis, liver ascites, alcoholic liver, fatty liver, and liver cirrhosis. Background technique [0002] The social nature of chronic hepatitis and its high prevalence rate determine its importance in epidemiology. It will cause the patient to lose the ability to work for a long time, become disabled, and have a high mortality rate. These indicators have all trended upwards over the years. At present, there are more than 400 million liver disease patients in the world, and liver disease is one of the diseases that seriously affect human health. [0003] According to the source of disease, chronic hepatitis is divided into: autoimmune hepatitis, chronic hepatitis B, chronic hepatitis C, chronic hepatitis D, chronic viral...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8905A61K36/71A61K36/258A61K36/236A61K36/06A61K35/54A61P1/16A61P31/12A61K35/57
Inventor 吕运一
Owner 深圳利孚生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products